Michael A. Metzger - Jul 7, 2022 Form 4 Insider Report for CTI BIOPHARMA CORP (CTIC)

Role
Director
Signature
/s/ Bruce Seeley, attorney-in-fact for Michael A. Metzger
Stock symbol
CTIC
Transactions as of
Jul 7, 2022
Transactions value $
-$130,995
Form type
4
Date filed
7/11/2022, 04:51 PM
Previous filing
Jul 8, 2022
Next filing
Jul 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTIC common stock Sale -$58.5K -9K -44.73% $6.50 11.1K Jul 7, 2022 Direct F1
transaction CTIC common stock Sale -$38.4K -5.9K -53.05% $6.51 5.22K Jul 7, 2022 Direct F1
transaction CTIC common stock Sale -$21.7K -3.32K -63.61% $6.52 1.9K Jul 7, 2022 Direct F1
transaction CTIC common stock Sale -$2.61K -400 -21.05% $6.53 1.5K Jul 7, 2022 Direct F1
transaction CTIC common stock Sale -$2.62K -400 -26.67% $6.54 1.1K Jul 7, 2022 Direct F1
transaction CTIC common stock Sale -$7.21K -1.1K -100% $6.55 0 Jul 7, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a 10b5-1 sales plan adopted by the Reporting Person.